Vitamins for the management of cardiovascular disease: a simple solution to a complex problem?

Area of Science:

• Cardiovascular Medicine
• Nutritional Science
• Biochemistry

Background:

• Growing interest in the link between homocysteine levels and cardiovascular disease (CVD).
• Epidemiologic studies suggest a correlation between high homocysteine and CVD, but causality is unproven.
• B vitamins are integral to homocysteine metabolism, prompting increased prescription for CVD management.

Purpose of the Study:

• To review the relationship between homocysteine and cardiovascular disease.
• To evaluate the role of B vitamins and antioxidant vitamins, specifically vitamin E, in managing cardiovascular disease.
• To determine the clinical utility of vitamin supplementation in cardiovascular disease patients.

Main Methods:

• Literature review of epidemiologic studies and clinical trials.
• Analysis of the biochemical pathways involving homocysteine and B vitamins.
• Examination of data on vitamin E's effect on myocardial infarction (fatal and nonfatal).

Main Results:

• A potential association between elevated homocysteine and CVD exists, though not definitively causal.
• Vitamin E supplementation may lower the risk of nonfatal myocardial infarction in coronary artery disease patients.
• The benefit of vitamin E in preventing fatal myocardial infarction remains unproven.

Conclusions:

• Vitamin supplements are not universally indicated for all cardiovascular disease patients.
• Targeted vitamin supplementation may be beneficial for specific patient subgroups with cardiovascular disease.
• Further research is needed to clarify the causal role of homocysteine and the precise benefits of vitamin supplementation in CVD.